Brief: Senzime Says ASA Approves Guidelines For Neuromuscular Blockade Monitoring

Senzime AB (publ)

27/10/2022 11:19

Oct 27 (Reuters) - Senzime AB (publ)  SEZI.ST :
    * NEW US CLINICAL GUIDELINES WILL RECOMMEND SENZIME'S TYPE
OF
TECHNOLOGY FOR PATIENT MONITORING
    * AMERICAN SOCIETY OF ANESTHESIOLOGISTS (ASA) HAS VOTED ON
FINAL
APPROVAL OF CLINICAL GUIDELINES FOR MONITORING AND REVERSAL OF
NEUROMUSCULAR BLOCKADE

Source text for Eikon:  ID:nMFNbZ7dKH 
Further company coverage:  SEZI.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))